TATVA NSE filing

Tatva Chintan Pharma Chem Announces Record Date, Book Closure, and Cut-off for 29th AGM and FY25 Final Dividend

The RealCase readMedium impact Neutral

Why it matters

The announcement directly impacts shareholders by setting the record date for the final dividend for FY 2024-25 and the cut-off date for e-voting at the 29th AGM, affecting their financial entitlement and participation rights in a key corporate event.

The market read

The announcement provides procedural details for the upcoming 29th Annual General Meeting, including book closure, record date for dividend, and e-voting cut-off. While a dividend is generally positive for shareholders, the announcement primarily conveys administrative information without new financial performance data or strategic changes, hence neutral.

* Tatva Chintan Pharma Chem Limited has announced the Record Date, Book Closure, and Cut-off date for its 29th Annual General Meeting (AGM) and final dividend for the Financial Year 2024-25. * The Register of Members and Share Transfer Books of the Company will remain closed from Saturday, 13 September 2025 to Friday, 26 September 2025 (both days inclusive). * The 29th AGM is scheduled to be held on Friday, 26 September 2025, at 04:00 p.m. (IST) through Video Conference/Other Audio Visual Means. * Friday, 12 September 2025, has been fixed as the Record Date for determining the equity shareholders entitled to the final dividend for Financial Year 2024-25. * The dividend, if approved by the Members at the AGM, will be paid on or after Friday, 03 October 2025. * The cut-off date for shareholders to exercise their right to vote by electronic means during the e-voting period for the 29th AGM is Friday, 19 September 2025.

Filing to action

What to do with a filing like this

Tatva Chintan Pharma Chem Limited filed this with the NSE as a statutory disclosure, categorised under corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Tatva Chintan Pharma Chem Limited. Read the original for the full detail.

View original filing